Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Baudax Bio Inc. (BXRX)

3.68   -0.06 (-1.6%) 07-08 10:38
Open: 3.69 Pre. Close: 3.74
High: 3.85 Low: 3.61
Volume: 180,492 Market Cap: 65M
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company's early-stage product candidates includes RP1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; and RP2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and a reversal agent, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.909 - 3.935 3.935 - 3.958
Low: 3.628 - 3.66 3.66 - 3.689
Close: 3.691 - 3.741 3.741 - 3.786

Technical analysis

as of: 2020-07-08 10:26:02 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.98     One year: 5.52
Support: Support1: 3.51    Support2: 2.92
Resistance: Resistance1: 4.26    Resistance2: 4.73
Pivot: 3.98
Moving Average: MA(5): 3.85     MA(20): 3.94
MA(100): 4.16     MA(250):
MACD: MACD(12,26): 0.01     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 17.79     %D(3): 25.42
RSI: RSI(14): 45.51
52-week: High: 10.14  Low: 2.16  Change(%): -46.4
Average Vol(K): 3-Month: 95715  10-Days: 90970

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BXRX has closed above bottom band by 26.6%. Bollinger Bands are 52.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to BXRX's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 07 Jul 2020
Is Now the Time to Invest in Baudax Bio Inc. (NASDAQ:BXRX)? - The Oracle Dispatch

Sun, 05 Jul 2020
Hedge Funds Keep Buying Baudax Bio, Inc. (BXRX) - Yahoo Finance

Fri, 03 Jul 2020
Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Tue, 30 Jun 2020
Baudax Bio, Inc. (NASDAQ:BXRX) slides -2.68% in recent trade, what to expect next? - Stocks Register

Mon, 29 Jun 2020
How Does Baudax Bio Inc (BXRX) Stock Rank Against the Competition? - InvestorsObserver

Mon, 29 Jun 2020
Baudax Bio Inc. (BXRX) latest performance of 4.43% is not what was on cards - News Daemon

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18
Shares Float (M) 12
% Held by Insiders 1.68
% Held by Institutions 116.04
Shares Short (K) 2,510
Shares Short P. Month (K) 1,980

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -35.8
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.772
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -17

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -1.57

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.